PortViewPortView
Sunshine Biopharma logo

Sunshine Biopharma (SBFMW) Stock Analysis

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$0.03+0.00%
1-year price historyRange $0.03 – $0.58
52-week range$0.03
$0.03$0.24

What Sunshine Biopharma does

Sunshine Biopharma, Inc. operates as a pharmaceutical and nutritional supplement company primarily dedicated to the research and development of innovative anticancer drugs. The company's pipeline includes Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin. This compound is currently in development to address a broad spectrum of cancers, such as leukemia, lymphoma, and tumors affecting the testicular, lung, brain, prostate, bladder, colon, ovarian, and liver. Significantly, Adva-27a has also shown effectiveness against multidrug-resistant cancer cells, including those associated with pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma. Another key therapeutic in development is SBFM-PL4, an anti-coronavirus treatment compound. In addition to its pharmaceutical endeavors, Sunshine Biopharma offers a range of nutritional supplements, including the Essential 9 tablet and the Essential Calcium-Vitamin D supplement, and continues to develop and market other scientifically-formulated nutritional products. The company has forged a licensing agreement with the University of Georgia to further the development of its lead anti-coronavirus compound, SBFM-PL4. Sunshine Biopharma, Inc. is based in Pointe-Claire, Canada.

Key metrics

Market cap
$155,180
EPS (TTM)
$-11.30
Beta
1.31
Dividend yield
0.00%
Revenue / share
$25.89
50-day avg
$0.05
200-day avg
$0.13
52-week high
$0.24
52-week low
$0.03
CEO
Steve N. Slilaty

ETFs linked to SBFMW

Broad-market and Healthcare sector ETFs an investor holding Sunshine Biopharma is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SBFMW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SBFMW in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Sunshine Biopharma?
Sunshine Biopharma trades under the ticker SBFMW on NASDAQ.
Which exchange is SBFMW listed on?
SBFMW is listed on NASDAQ.
What sector does Sunshine Biopharma operate in?
Sunshine Biopharma is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze SBFMW in a portfolio?
PortView shows SBFMW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.